What they were paid
Kura Oncology Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $90,215 | $0 | $116,035 | $0 | $206,250 |
| FY2024 | $85,000 | — | $341,071 | — | $426,071 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Kura Oncology, Inc. DEF 14A filed April 10, 2026, accession 0001193125-26-151335, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Kura Oncology pays directors a $45,000 cash retainer and $35,000 in Options.
Committees
FY2025 · as the proxy prints themAudit · Compensation
The rest of the Kura Oncology board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Carol Schafer | Independent Director | $186,250 |
| Diane Parks | Independent Director | $173,750 |
| Helen Collins, M.D | Independent Director | $173,750 |
| Mary T. Szela | Independent Director | $186,250 |
| Michael Vasconcelles, M.D | Independent Director | $168,750 |
| Thomas Malley | Independent Director | $181,250 |
| Troy E. Wilson, Ph.D., J.D | Chair of the Board | $0 |
The full Kura Oncology compensation record
free company briefThis page is one director within Kura Oncology's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat